Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies
Abstract Vaccine development targeting rapidly evolving pathogens such as HIV-1 requires induction of broadly neutralizing antibodies (bnAbs) with conserved paratopes and mutations, and in some cases, the same Ig-heavy chains. The current trial-and-error search for immunogen modifications that impro...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-53120-9 |